Gregg L. Katz

Gregg Katz, a partner in Goodwin’s Technology group, works on a wide variety of public and private securities offerings, mergers and acquisitions and other complex transactions. His practice centers on technology and life sciences companies, including clients in the software, hardware, biotechnology, pharmaceuticals, and other technology-driven industries.

Gregg’s representation of start-up and later-stage companies spans the entire corporate lifecycle, including pre-incorporation planning, venture capital financings, public offerings, SEC reporting and disclosure, mergers and acquisitions, and general corporate representation and counseling.

Gregg is a member of the firm’s Hiring and Pro Bono Committees.

Gregg’s transactional experience includes representing: 

Public Offerings - Issuer

• Toast, the all-in-one digital platform built for restaurants, in its $1.0 billion initial public offering on NYSE
• Moderna, a pioneer of mRNA therapeutics and vaccines, in its $604 million initial public offering on NASDAQ and in its $575 million and $1.3 billion follow-on offerings
• Enfusion, a leading provider of cloud-based investment management software and services, in its $367 million initial public offering on NYSE
• bluebird bio, a biotechnology company developing gene therapies for severe genetic diseases and T cell-based immunotherapies for cancer, in its $116 million initial public offering on NASDAQ and in eight follow-on public offerings totaling $3.5 billion
• Alnylam Pharmaceuticals, a leading RNAi therapeutics company, in four follow-on public offerings totaling $2.9 billion
• Aquaventure Holdings, a multinational provider of water-as-a-service solutions, in its $135 million initial public offering on NYSE and its $80 million follow-on offering
• Eloqua, a provider of on-demand revenue performance management software solutions, in its $106 million initial public offering on NASDAQ
• Omthera Pharmaceuticals, a pharmaceutical company focused on therapies for abnormalities in blood lipids and the treatment of cardiovascular disease, in its $64 million initial public offering on NASDAQ

Public Offerings - Underwriter

• J.P. Morgan, Goldman Sachs and Morgan Stanley in the $924 million initial public offering of Bright Health Group on NYSE
• Goldman Sachs and Morgan Stanley in the $300 million initial public offering of Blue Apron on NYSE
• Goldman Sachs and Credit Suisse in the $113 million initial public offering of Alarm.com on NASDAQ
• Goldman Sachs and Deutsche Bank in the $235 million and $344 million follow-on public offerings of CyberArk Software
• J.P. Morgan and Deutsche Bank in the $99 million initial public offering of CyberArk Software on NASDAQ
• Goldman Sachs and Credit Suisse in the $133 million initial public offering of 2U on NASDAQ and in three follow-on offerings totaling $688 million
• Stifel in the $57 million initial public offering of SPS Commerce on NASDAQ and in four follow-on offerings totaling $172 million

Private Financings

• Toast, the all-in-one digital platform built for restaurants, in its Series B, Series C, Series D, Series E and Series F financings
• Salsify, the Commerce Experience Management platform empowering brand manufacturers, in its Series A, Series B, Series C, Series D, Series E and Series F financings
• Dutchie, the technology platform powering cannabis commerce, in its Series C and Series D financings
• Circle Internet Financial, a digital currency company, in its Series A, Series B, Series C, Series D, Series E and Series F financings, as well as its convertible note financing
• Carrot Fertility, a leading global fertility benefits provider for employers, in its Series D financing
• Alnylam Pharmaceuticals, a leading RNAi therapeutics company, in a $700 million equity financing closed in connection with Alnylam’s collaboration with Sanofi Genzyme, a $400 million equity financing closed in connection with Alnylam’s collaboration with Regeneron, and a $100 million equity financing closed in connection with Alnylam’s collaboration with Blackstone
• 2seventy bio, an immuno-oncology cell therapy company, in a $170 million PIPE financing
• OM1, a leading health outcomes and technology company, in its Series B, Series C and Series D financings
• Encamp, an enterprise technology startup for environmental compliance data management and reporting, in its Series C financing
• Wellframe, a digital health management platform, in its Series C financing
• Optum Ventures in numerous portfolio company investments
• Seven Bridges Genomics in its Series B and Series C financings
• Carrick Therapeutics, a European oncology company, in each of its funding rounds
• Genomics Medicine Ireland, an Irish genomics research company, in its Series A financing
• TellusLabs, a leader in the use of satellite imaging for developing agricultural insights, in its seed financing
• Sansoro Health, a pioneer in data integration for health care, in its Series B financing
• Innophase, an innovative semiconductor company, in its financing rounds
• Infinio Systems, a leader in storage acceleration for virtualized data centers, in its financing rounds and subsequent sale
• Bedford Funding in its Series C and Series D investments in Voalte and Series D investment in MDLIVE

Mergers & Acquisitions

• Salsify, the Commerce Experience Management platform empowering brand manufacturers, in its acquisitions of Alkemics and SKUvantage
• Circle Internet Financial, a digital currency company, in the acquisition and subsequent spin-out of the Poloniex cryptocurrency trading platform and in the acquisition of SeedInvest
• Checkr, a technology platform for employment background checks, in its acquisition of GoodHire
• Toast, the all-in-one digital platform built for restaurants, in its acquisition of Sling
• iRobot Corporation, a leading global consumer robot company in its acquisitions of Robopolis SAS, Evolution Robotics, Root Robotics and Aeris Cleantec, and in the sale of its Defense & Security business to Arlington Capital Partners
• Wellframe, a digital health management platform, in its sale to HealthEdge
• Roman DBDR Tech Acquisition Corp. in its business combination with CompoSecure
• Teva Pharmaceutical Industries, a leading global pharmaceutical company, in the sale of its specialty women’s global health business
• Neumora Therapeutics, a clinical-stage biotechnology company pioneering precision medicines for brain diseases through the integration of data science and neuroscience, in its acquisition of Blackthorn Therapeutics
• Genomics Medicine Ireland, an Irish genomics research company, in its sale to WuXi NextCODE
• Sansoro Health, a pioneer in data integration for health care, in its acquisition of Datica Health
• Cobalt Biomedicine, a biotechnology company, in its sale to Sana Biotechnology
• TellusLabs, a leader in the use of satellite imaging for developing agricultural insights, in its sale to Indigo Agriculture
• RedBrick Health, a health engagement and behavior-based technology company, in its sale to Marlin Equity Partners
• Code42 Software, a leader in cloud-based endpoint data protection and recovery, in the sale of its consumer business to Carbonite
• Plex Systems, a leader in cloud ERP for manufacturing, in its acquisitions of DemandCaster, DATTUS and Kors Engineering
• bluebird bio, a biotechnology company developing gene therapies for severe genetic diseases and T cell-based immunotherapies for cancer, in its acquisition of Precision Genome Engineering
• Eloqua, a leading provider of on-demand revenue performance management software solutions, in its sale to Oracle Corporation
• Endeca Technologies, a provider of unstructured data management, web commerce and business intelligence solutions, in its sale to Oracle Corporation
• WaveMark, a provider of real-time healthcare supply chain solutions, in its sale to Cardinal Health

Gregg is a member of the Massachusetts and Boston Bar Associations. He also serves on the board of directors of the Hillel Council of New England.

Gregg's speaking engagements have included:

• “Becoming a Public Company” at the 2017-2019 and 2021-2022 KPMG IPO Bootcamps
• “Preparing for Going Public: Lessons Learned from the 2021 Boom” sponsored by Deloitte